CSIMarket
 
Genetic Technologies Limited  (GENE)
Other Ticker:  
 
 


GENE reported fourth quarter of 2019 operating loss of $-4.657098 millions

Published -0001-11-30T00:00:00+00:00
Goran Soko / CSIMarket.com Contributer

closeup_By_Jean-Etienne_Minh-Duy_Poirrier_from_Bruxelles_Belgium_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_CommonsFor the financial time-frame closing June 30 2019 GENE reached balanced books of $0.00 per share compare to $0.00 a year before and from $0.00 per share from the preceding financial reporting period.

Revenues dropped sharply by -86.556 % to $0.03 millions from $0.19 millions in the corresponding financial reporting period a year before and sequentially from $0.00 millions.




For the financial time-frame closing June 30 2019 Genetic Technologies Limited realized net loss of $-6.426 million, higher than $-5.464 million a year ago.

the Biotechnology & Pharmaceuticals company recorded loss of $-6.43 millions and Revenues of $0.03 millions in the fiscal year 2019.

Genetic Technologies Limited reported as well balanced books from $0.00 in the preceding fiscal year, while by -86.56 % from $0.19 millions a year before.

Genetic Technologies Limited is expected to report next financial results on August 29, 2023.


    Recently Reported Results
customer_service_By_User_Mattes_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Rxo Inc

For the financial time-frame closing September 30 2022 RXO earnings per share remained unchanged of $0.11 per share compare to $0.00 a year ago and from $0.00 per share from the previous financial reporting period.

Revenues increased sharply by 601208.295 % to $1.14 billions from $0.19 millions in the similar financial reporting period a year ago and sequentially from $0.00 millions.

Supercenter_Theonlysilentbob_at_en.wikipedia__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Retail Sales

Retail sales accelerate in October 2022

The rate of growth in retail and food services total sales accelerated due to increase in higher sales on gasoline stations.

Dryvax_pd Cell Source Inc

In the fiscal interval ending second quarter of 2022 operating deficit embodied progress to $-1.121356 millions, at the Cell Source Inc

The stockholders did not assume any adjustments at the revenue during the the April to June 30 2022 reporting season at the Cell Source Inc . Yet, investors observe the Major Pharmaceutical Preparations company's operating deficit which came in at $-1.033877 millions, during the same period.

Advance monthly sales full report

Advance monthly sales growth

Petit_dejeuner_Bordeaux_By_LenaRosemberg_User_Lena_(Flickr_Bordeaux_9584)__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Iconic Brands Inc

A shortfall of $-0.05 per Share at the Nonalcoholic Beverages company in the most recent fiscal period

Although company's Revenues increased by 11.101 % from the corresponding financial reporting period a year before to $3.16 millions in the Sep 30 2022 report, Iconic Brands Inc lost money at $-0.05 shortfall per share.

Advance monthly sales full report

Advance monthly sales growth

money-2180330_960_720 Qiansui International Group Co Ltd

The ascending entity from the Blank Checks sector the Qiansui International Group Co Ltd published the most recent fiscal period, results

The Blank Checks sector contributors continue to digest the third quarter of 2022 earnings. Today those contributors follow operating loss of $-0.01449 millions, from the ACEZ, which hasn't specified any revenue yet, for the own July to September 30 2022 reporting period.

Advance monthly sales full report

Advance monthly sales growth

Montage_By_Michael_Schmahl_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Construction Spending

In September 2022 growth in construction spending slows

Outlays for U.S. construction projects continue to grow but on the slower pace, mainly because of declining construction outlays for health care by -2.6 %.

Loxley_Farm_Market_Produce_By_Infrogmation_of_New_Orleans_[CC-BY-SA-3.0_(http_creativecommons.org_licensesby-sa3.0)]_via_Wikimedia_Commons Consumer Price Index

Consumer prices increased in October 2022


unemployed_lines_pd Employment Report

Economy gains 261,000 jobs, but the unemployment rate climbs to 3.7 %

The nonfarm payrolls grew 261,000 in October, as faster hiring puts more money in the hands of consumers, what usually leads to an increase in spending,

marijuana-leaf-694336_960_720 Leafly Holdings Inc

Leafly Holdings Inc announced Revenue of $11.781 millions, in the July to September 30 2022

the Legal Cannabis company disclosed $11.781 millions, in Revenue in the third quarter of 2022 earnings season.

Job growth by Industry

Salary by Industry

women_app_By_J_P_Karna_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Victorias Secret And Co

Victorias Secret And Co disclosed a steep -8.536 %, contraction in Revenues, in the most recent fiscal period

Softness in Revenues caused earnings to tumble by -64.2 % to $0.29 per share, from $0.81 per share, where Revenues fell by -8.536 % to $1.32 billions in the fiscal period ending October 29 2022, relative to similar quarter a year prior.

Job growth by Industry

Salary by Industry

dna-163466__340 Bioaffinity Technologies Inc

The company disclosed devastating Revenues slide, over the third quarter of 2022 earnings season

For the most recent fiscal period Bioaffinity Technologies Inc slipped into shortfall of $-1.17 per share compare to $0.81 a year ago and earnings per share fell from $0.83 per share from the preceding reporting season.

Revenues went down sharply to $0.00 millions from $1.44 billions in the corresponding reporting season a year ago and sequentially Revenue deteriorated from $1.52 billions.

Job growth by Industry

Salary by Industry

Marijuana_leaf_at_Veer_Guest_House,_Manali_(164703748) Wm Technology Inc

MAPS has Slipped into deficit at the Legal Cannabis company over the third quarter of 2022 earnings season

For the third quarter of 2022 earnings season Wm Technology Inc slipped into shortfall of $-0.06 per share compare to $0.02 a year prior and Income per Share fell from $0.13 per share from the previous financial reporting period.

Revenues decreased by -0.755 % to $50.50 millions from $50.88 millions in the similar financial reporting period a year prior and sequentially Revenue deteriorated by -13.37 % from $58.29 millions.

Job growth by Industry

Salary by Industry

Marijuana_leaf_at_Veer_Guest_House,_Manali_(164703748) Leaf Group Ltd

Fascinating behavior by the company over the first quarter of 2021

For the January to March 31 2021 time-frame company lost money of $-0.18 per share compare to $-0.40 a year before and increased shortfall from $-0.09 per share from the previous reporting period.

Revenues rose strongly by 57.855 % to $51.88 millions from $32.87 millions in the similar reporting period a year before and sequentially Revenues fell by -20.182 % from $65.00 millions.

Job growth by Industry

Salary by Industry

Allure_of_the_SeasBy_Makele-90_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Cedar Fair L P

Strong Eps Underlines Double Digits Revenues growth at in the third quarter of 2022 earnings season

Underlining the fiscal period ending September 25 2022 net profit per share improved significantly by 126.44 % to $5.91 per share, followed by Revenue increment of 11.901 % to $843.06 millions, compared with the prior year period.

Job growth by Industry

Salary by Industry



Other GENE's Earnings Reports

Genetic Technologies Limited reported second quarter 2022 earnings

Genetic Technologies Limited reported first quarter 2022 earnings

Genetic Technologies Limited reported fourth quarter 2021 earnings

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

RSRV's Profile

Stock Price

RSRV's Financials

Business Description

Fundamentals

Charts & Quotes

RSRV's News

Suppliers

RSRV's Competitors

Customers & Markets

Economic Indicators

RSRV's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071